Department of Cardiology, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Guang Xi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Disease Control and Prevention, Nanning, 530021, Guangxi, China.
BMC Cardiovasc Disord. 2023 Feb 1;23(1):58. doi: 10.1186/s12872-023-03043-y.
BACKGROUND/AIMS: The activation of the complement system and subsequent inflammatory responses are important features of myocardial ischemia/reperfusion (I/R) injury. Exosomes are nanoscale extracellular vesicles that play a significant role in remote ischemic preconditioning (RIPC) cardioprotection. The present study aimed to test whether RIPC-induced plasma exosomes (RIPC-Exo) exert protective effects on myocardial I/R injury by inhibiting complement activation and inflammation and whether exosomal heat shock protein 90 (HSP90) mediates these effects.
Rat hearts underwent 30 min of coronary ligation followed by 2 h of reperfusion. Plasma exosomes were isolated from RIPC rats and injected into the infarcted myocardium immediately after ligation. Sixty rats were randomly divided into Sham, I/R, I/R + RIPC-Exo (50 µg/µl), and RIPC-Exo + GA (geldanamycin, 1 mg/kg, administration 30 min before ligation) groups. Cardiomyocyte apoptosis, the release of myocardial markers (LDH, cTnI and CK-MB), infarct size, the expression of HSP90, complement component (C)3, C5a, c-Jun N-terminal kinase (JNK), interleukin (IL)-1β, tumor necrosis factor (TNF)-alpha and intercellular adhesion molecule -1 (ICAM-1) were assessed.
RIPC-Exo treatment significantly reduced I/R-induced cardiomyocyte apoptosis, the release of myocardial markers (LDH, cTnI and CK-MB) and infarct size. These beneficial effects were accompanied by decreased C3 and C5a expression, decreased inflammatory factor levels (IL-1β, TNF-α, and ICAM-1), decreased JNK and Bax, and increased Bcl-2 expression. Meanwhile, the expression of HSP90 in the exosomes from rat plasma increased significantly after RIPC. However, treatment with HSP90 inhibitor GA significantly reversed the cardioprotection of RIPC-Exo, as well as activated complement component, JNK signalling and inflammation, indicating that HSP90 in exosomes isolated from the RIPC was important in mediating the cardioprotective effects during I/R.
Exosomal HSP90 induced by RIPC played a significant role in cardioprotection against I/R injury, and its function was in part linked to the inhibition of the complement system, JNK signalling and local and systemic inflammation, ultimately alleviating I/R-induced myocardial injury and apoptosis by the upregulation of Bcl-2 expression and the downregulation of proapoptotic Bax.
背景/目的:补体系统的激活和随后的炎症反应是心肌缺血/再灌注(I/R)损伤的重要特征。外泌体是一种纳米级细胞外囊泡,在远程缺血预处理(RIPC)的心脏保护中发挥重要作用。本研究旨在探讨 RIPC 诱导的血浆外泌体(RIPC-Exo)是否通过抑制补体激活和炎症来发挥对心肌 I/R 损伤的保护作用,以及外泌体热休克蛋白 90(HSP90)是否介导这些作用。
大鼠心脏进行 30 分钟的冠状动脉结扎,然后再灌注 2 小时。从 RIPC 大鼠中分离出血浆外泌体,并在结扎后立即注入梗死心肌。将 60 只大鼠随机分为 Sham、I/R、I/R+RIPC-Exo(50μg/μl)和 RIPC-Exo+GA(geldanamycin,1mg/kg,结扎前 30 分钟给药)组。评估心肌细胞凋亡、心肌标志物(LDH、cTnI 和 CK-MB)释放、梗死面积、HSP90、补体成分(C)3、C5a、c-Jun N-末端激酶(JNK)、白细胞介素(IL)-1β、肿瘤坏死因子(TNF)-α和细胞间黏附分子-1(ICAM-1)的表达。
RIPC-Exo 治疗显著减少了 I/R 诱导的心肌细胞凋亡、心肌标志物(LDH、cTnI 和 CK-MB)释放和梗死面积。这些有益作用伴随着 C3 和 C5a 表达的减少、炎症因子水平(IL-1β、TNF-α和 ICAM-1)的降低、JNK 和 Bax 的减少以及 Bcl-2 的表达增加。同时,大鼠血浆外泌体中 HSP90 的表达在 RIPC 后显著增加。然而,HSP90 抑制剂 GA 的治疗显著逆转了 RIPC-Exo 的心脏保护作用,以及激活的补体成分、JNK 信号和炎症,表明 RIPC 诱导的外泌体中的 HSP90 在介导 I/R 期间的心脏保护作用中起重要作用。
RIPC 诱导的外泌体 HSP90 在对抗 I/R 损伤的心脏保护中发挥了重要作用,其功能部分与抑制补体系统、JNK 信号和局部及全身炎症有关,最终通过上调 Bcl-2 表达和下调促凋亡 Bax 表达,减轻 I/R 诱导的心肌损伤和凋亡。